Skeletal Muscle and Brown Adipose Mechanisms Mediating Cardiovascular Risk Factor Protection in RGS14 KO
RGS14 KO 中骨骼肌和棕色脂肪机制介导心血管危险因素保护
基本信息
- 批准号:9900047
- 负责人:
- 金额:$ 53.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adipose tissueAgingBrown FatCaloric RestrictionCardiac DeathClinicalCountryDataDevelopmentDiabetes MellitusDietDiseaseEnergy MetabolismEpidemicExcisionFatty acid glycerol estersFemaleGTP-Binding Protein RegulatorsGTP-Binding ProteinsGeneticGlucoseGlucose IntoleranceGoalsHealthHealth Care CostsHeart DiseasesInsulin ResistanceKnock-outKnockout MiceLongevityMediatingMitochondriaModelingMusNon-Insulin-Dependent Diabetes MellitusObesityOxidative StressPalatePathway interactionsPatientsPharmacologyPopulationSIRT1 geneSOD2 geneSignal PathwaySignaling ProteinSkeletal MuscleSpecificityStressStriated MusclesTransplantationWild Type Mouseaging populationbasecardiovascular risk factorcompliance behaviordietary restrictiongender differenceglucose metabolismimprovedinhibitor/antagonistmalenovelnovel therapeuticsoxidationprotective effect
项目摘要
Project Summary:
We have generated a mouse knockout (KO) of the regulator of G protein signaling 14 (RGS14). The RGS14 KO
mice live longer than their wild type (WT) littermates and are protected against stress, type 2 diabetes and
obesity, all features related to cardiovascular risk protection. The mechanisms mediating these salutary effects
of the RGS14 KO involve the striated muscle. The RGS14 KO also has increased brown adipose tissue, which
is likely involved in the mechanism of its protective effects. The goal of this proposal is to determine the
mechanisms mediating these salutary actions. We plan to establish the RGS14 KO as a novel model for longevity
and determine to what extent striated muscle specific loss of RGS 14 and brown adipose tissue contribute to
longevity, and protection against obesity and diabetes. In this proposal “diabetes” is used to reflect protection of
glucose utilization and insulin resistance, rather than the clinical disease.
Our long term goal is to develop a clinically useful pharmacological inhibitor of RGS14.
The proposal is based on the following hypotheses:
Hypothesis A: Striated muscle specificity of RGS14 KO protects against the development of insulin resistance,
glucose intolerance and obesity and extends lifespan mediated by increased energy metabolism through
mitochondrial oxidation and protection against oxidative stress through the NAD+/SIRT3/MnSOD pathway.
Hypothesis B: The RGS14 KO has the additional novel feature of increased brown adipose tissue, which also
protects against diabetes, obesity and prolongs lifespan.
项目摘要:
我们已经产生了G蛋白信号转导调节因子14(RGS 14)的小鼠敲除(KO)。RGS14 KO
小鼠比它们的野生型(WT)同窝出生的小鼠活得更长,并且免受应激、2型糖尿病和
肥胖,所有与心血管风险保护相关的特征。调节这些有益效果的机制
RGS 14 KO的表达涉及横纹肌。RGS 14 KO还具有增加的棕色脂肪组织,
可能参与其保护作用的机制。本提案的目的是确定
调节这些有益行为的机制。我们计划建立RGS 14 KO作为长寿的新模型
并确定横纹肌特异性RGS 14和棕色脂肪组织的损失在多大程度上有助于
长寿,预防肥胖和糖尿病。在这一建议中,“糖尿病”被用来反映保护
葡萄糖利用和胰岛素抵抗,而不是临床疾病。
我们的长期目标是开发临床上有用的RGS 14药理学抑制剂。
该提案基于以下假设:
假设A:RGS 14 KO的横纹肌特异性防止胰岛素抵抗的发展,
葡萄糖耐受不良和肥胖,并通过增加能量代谢延长寿命,
通过NAD+/SIRT 3/MnSOD途径保护线粒体氧化和对抗氧化应激。
假设B:RGS 14 KO具有增加的棕色脂肪组织的额外新特征,其还
预防糖尿病、肥胖和延长寿命。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN F VATNER其他文献
STEPHEN F VATNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN F VATNER', 18)}}的其他基金
A Novel Pharmacological Inhibitor of Adenylyl Cyclase Type 5 to Treat Alzheimer's Disease
一种治疗阿尔茨海默病的新型 5 型腺苷酸环化酶药理抑制剂
- 批准号:
10608477 - 财政年份:2022
- 资助金额:
$ 53.43万 - 项目类别:
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk
sFRP3 肌细胞/血管交互作用诱导的血管生成保护
- 批准号:
9900045 - 财政年份:2017
- 资助金额:
$ 53.43万 - 项目类别:
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection
RGS 14 破坏、血管效应导致心脏保护
- 批准号:
8888575 - 财政年份:2015
- 资助金额:
$ 53.43万 - 项目类别:
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection
RGS 14 破坏、血管效应导致心脏保护
- 批准号:
9102537 - 财政年份:2015
- 资助金额:
$ 53.43万 - 项目类别:
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KO
RGS14 KO 中提高运动耐力的骨骼肌基础
- 批准号:
9513046 - 财政年份:2011
- 资助金额:
$ 53.43万 - 项目类别:
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO
AC5 KO 中提高运动耐力的骨骼肌基础
- 批准号:
8193326 - 财政年份:2011
- 资助金额:
$ 53.43万 - 项目类别:
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO
AC5 KO 中提高运动耐力的骨骼肌基础
- 批准号:
8497469 - 财政年份:2011
- 资助金额:
$ 53.43万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 53.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 53.43万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 53.43万 - 项目类别:
Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 53.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 53.43万 - 项目类别:
Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 53.43万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 53.43万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 53.43万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 53.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 53.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)